Fight against COVID-19
Resume Operations Rapidly
With great preparation work to guarantee a safe workplace, Singclean Medical was among the first 278 companies in Qiantang New District to be approved to resume operations on 11 February while COVID-19 epidemic had been gradually brought under control in Zhejiang, China.
Thanks to our staff, all works are being carried out in an orderly manner.
Care for Employees

We always put the health of our employees in the first priority. Over 90,000 dollars worth of goods including oranges, masks, spraying disinfectants were urgently purchased to be distributed to Singclean employees to help them maintain health and protect them from the virus.
Giving Back to the Community

Singclean Medical thinks highly about social responsibility and has been making contributions to the community since the outbreak of COVID 19. More than 2,968,000 dollars was donated to help fight the COVID-19 pandemic before 21 February.
With its expertise in medical device industry, Singclean Medical sent more than 50 sets of disinfection channels valued at over 424,000 dollars to key COVID-19 prevention and control units, mainly to medical institutions. These channels contained the most advanced disinfection sprayers used in purification workshop of pharmaceutical factories and the quaternary ammonium salt disinfectants which were regarded as the safest disinfectants. The cost of each set is ten times that of ordinary disinfection channel.
Besides, Singclean Medical fully subsidized the Beijing Zhongwei Research Center of biological and translational Medicine and cooperated with institutions like China Maternal and Child Health Association, Health Commission of Shangrao, Qiqihar Medical University. A Special Fund was set up to help prevent and control the outbreak of Novel Coronavirus Pneumonia, provide humanitarian assistance for frontline medical workers and fund the clinical researches of COVID-19 infected cases. The total amount of the special funds amounts to 2,453,000 dollars.
Research and Development

Singclean Medical always holds the belief that “Strong wind reveals the strength of grass, and gold is refined in fierce fire”.
When facing the outbreak of COVID-19, more resources was put into innovation aiming to develop a product to combat coronavirus. With our rich experience in developing IVD test kits using immunoassay technologies, Singclean® COVID-19 IgM/IgG Test Kit was launched in a short time. This test kit with CE mark is a solid phase immunochromatographic assay for rapidly detecting IgG and IgM antibodies in human whole blood, serum or plasma, acting as auxiliary diagnosis for patients infected with COVID-19. It is ideal for detecting suspected patients identified as being negative in nucleic acid test and asymptomatic patients. The test kits can quickly identify potential cases and help with quick treatment. Now, Singclean® COVID-19 IgM/IgG Test Kit have been shipped to different parts in the world to prevent the spread of the coronavirus.
-
singclean | 2020-05-27
2026 Global Dermal Filler Trend Outlook:As the global medical aesthetics market continues to evolve, consumer and clinician demands for dermal fillers are undergoing an unprecedented paradigm shift. From the early days of "blind filling and chasing volume" to today's focus on "anatomical refinement, natural facial dynamics, and ultimate comfort," the industry has officially entered the Hyaluronic Acid 4.0 Era. In this transformation driven by safety, comfort, longevity, and natural results, innovative Chinese brands like Singderm® are accelerating their breakthrough into the premium global aesthetics landscape, powered by proprietary technologies and rigorous international standards. -
singclean | 2020-05-27
Dual-Exhibition Global Layout! Singclean Medical to Showcase Premium Biomaterials and IVD Innovations at WHX Miami & WHX Bangkok 2026With the rapid advancement and technical iteration of the global healthcare industry, international presence has become the core engine for the sustainable growth of leading medical device enterprises. Hangzhou Singclean Medical Products Co., Ltd. (Singclean Medical), a globally recognized leader in medical biomaterials and In Vitro Diagnostics (IVD), has announced its upcoming participation in two world-class healthcare exhibitions from June to July 2026: WHX Miami (World Health Expo Miami 2026) in the United States and WHX Bangkok (World Health Expo Bangkok 2026) in Thailand. Singclean Medical will seize these opportunities to demonstrate its latest achievements under the dual-wheel drive of "Medical Biomaterials" and "In Vitro Diagnostics," cordially inviting global partners to explore new horizons in medical healthcare. -
singclean | 2020-05-27
Singclean Medical Shines at Mevos 2026 with Two New Singfiller Products, Ushering in a New Decade of Precision Filling